KMG Capital Partners

Circuit Clinical is an integrated research organization that has emerged from the experience of a physician engaged in clinical research within a private practice. Established in 2015, the company aims to enhance the way clinical research is conducted by emphasizing physician and participant engagement. Circuit Clinical leverages a network of over 1 million patients, utilizing direct HIPAA/FDA-compliant Electronic Medical Record reviews to identify motivated participants. The organization provides research services that facilitate access to clinical research, guiding both experienced and novice community physicians and their patients through each step of the clinical research process. Through its technology products and focus on participant and physician experience, Circuit Clinical seeks to improve research site quality and patient safety, creating a more efficient pathway for clinical research.

TriSalus Life Sciences specializes in developing precision infusion systems for interventional radiology, focusing on targeted drug delivery to treat liver cancer and other solid tumors. The company's flagship products include the Surefire precision infusion systems designed for lobar, segmental, and super-selective infusions, as well as guiding catheters. TriSalus also develops Pressure Enabled Drug Delivery (PEDD) infusion systems and investigational agents like nelitolimod to enhance immune response in cancer treatment.

Bottlenose, Inc. is a business intelligence software company that specializes in real-time data analysis to help enterprises identify threats and opportunities. Founded in 2010, the company is headquartered in San Francisco, California, with additional offices in Los Angeles and New York City. Its flagship product, Nerve Center, is a SaaS-based solution that enables analysts and strategists to monitor both internal and external factors affecting their businesses. By utilizing advanced machine learning, data mining, and predictive analytics, Nerve Center transforms complex data streams into actionable insights. The platform is designed to detect patterns and trends across various domains, including brand reputation, consumer insights, competitive intelligence, and crisis response. Bottlenose primarily serves Fortune 100 companies, assisting them in developing data-driven strategies to enhance customer engagement and optimize business performance.

Coherus Biosciences is a biopharmaceutical company focused on developing, manufacturing, and commercializing biologic therapeutics for oncology and inflammatory diseases. Its pipeline includes biosimilars for immunology, ophthalmology, and oncology.

Founded in 2012, Wildflower Health is a San Francisco-based company that specializes in smartphone-based health programs. It offers Due Date Plus for maternity care and GROW for family health, providing services such as reminders, provider look-up, and health risk assessments to support users and connect them with healthcare providers.

FitBionic Inc., established in 2006 and headquartered in Boulder, Colorado, specializes in designing and manufacturing prosthetic walking feet for individuals with conditions such as neuropathy, vascular disease, scarring, and fragile skin problems. The company's primary product, the FitBionic Foot, is designed to enhance efficiency, reduce pain and fall risk, and cater specifically to the needs of amputees with diabetes. Funded by the National Institutes of Health since its inception, FitBionic aims to provide high-quality, affordable prosthetic solutions that enable users to lead active lifestyles. The company operates through centers of excellence, ensuring whole-person care for its clients.